Literature DB >> 15077020

A delay in bone marrow transplantation after partial conditioning improves engraftment.

Hong Xu1, Beate G Exner, Paula M Chilton, Michael K Tanner, Yvonne M Mueller, Francine Rezzoug, Suzanne T Ildstad.   

Abstract

BACKGROUND: In the present study we examined the effect of the timing of marrow infusion on engraftment in nonmyeloablatively conditioned mice.
METHODS: B10 mice were conditioned with decreasing doses of total body irradiation (TBI) and reconstituted with bone marrow cells (BMCs) from major histocompatibility complex-disparate donor B10.BR mice at 0 or 6 hr, or on days 1, 2, 3, 4, 5, 8, and 12 with respect to TBI.
RESULTS: After undergoing conditioning with 700 cGy TBI and transplantation with 15 x 10(6) BMCs, 100% of recipients engrafted if the marrow was infused between 0 and 4 days after TBI. For lower doses of TBI, a delay in infusion of the marrow after TBI conditioning was associated with a significant increase in engraftment. Significantly less engraftment was achieved in animals conditioned with 600 cGy TBI if the marrow was infused at 0 or 6 hr compared with a 1- to 4-day delay. When the TBI was decreased to 500 cGy, engraftment occurred only when the transplant was performed between days 2 and 8. The highest proportion of recipients engrafted when the marrow was infused on day 4. This enhanced engraftment after a delay in marrow infusion is associated with a significant reduction in host mixed lymphocyte reaction reactivity and is correlated inversely with serum levels of interleukin-6 in the recipient.
CONCLUSIONS: These data demonstrate for the first time that a delay between conditioning and marrow infusion significantly improves allogeneic engraftment in nonmyeloablatively conditioned recipients and reduces the total conditioning required.

Entities:  

Mesh:

Year:  2004        PMID: 15077020     DOI: 10.1097/01.tp.0000116414.66171.81

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  Improved survival after single-unit cord blood transplantation using fludarabine and melphalan-based reduced-intensity conditioning for malignant lymphoma: impact of melphalan dose and graft-versus-host disease prophylaxis with mycophenolate mofetil.

Authors:  Kazuki Sakatoku; Sung-Won Kim; Hiroshi Okamura; Minoru Kanaya; Koji Kato; Satoshi Yamasaki; Naoyuki Uchida; Hikaru Kobayashi; Takahiro Fukuda; Nobuyuki Takayama; Jun Ishikawa; Hideyuki Nakazawa; Masatoshi Sakurai; Takashi Ikeda; Tadakazu Kondo; Satoshi Yoshioka; Toshihiro Miyamoto; Takafumi Kimura; Tatsuo Ichinohe; Yoshiko Atsuta; Eisei Kondo
Journal:  Ann Hematol       Date:  2022-10-05       Impact factor: 4.030

2.  Strategic nonmyeloablative conditioning: CD154:CD40 costimulatory blockade at primary bone marrow transplantation promotes engraftment for secondary bone marrow transplantation after engraftment failure.

Authors:  Hong Xu; Yiming Huang; Paula M Chilton; Lala-Rukh Hussain; Michael K Tanner; Jun Yan; Suzanne T Ildstad
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

3.  Delaying DLA-haploidentical hematopoietic cell transplantation after total body irradiation.

Authors:  Yunchuan Ding; Marcello Rotta; Scott S Graves; Barry E Storer; Laura J Peterson; George E Sale; Reza Forough; Eustacia Zellmer; George E Georges; Brenda M Sandmaier; Christian S Kuhr; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2009-08-03       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.